Alison Mosca - 16 Sep 2026 Form 4 Insider Report for Clene Inc. (CLNN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Sep 2026, 13:40:17 UTC
Prior SEC filing
14 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerome T. Miraglia POA

Key filing fact

Alison Mosca filed Form 4 for Clene Inc. (CLNN) on 18 Sep 2026.

Key facts

  • This page summarizes Alison Mosca's Form 4 filing for Clene Inc. (CLNN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Sep 2026, 13:40.

Change

  • Previous filing in this sequence was filed on 14 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001835537 Primary reporting owner

Mosca Alison

Relationship
Director, 10%+ Owner
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Signature
/s/ Jerome T. Miraglia POA
Signature date
18 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLNN transaction

common stock

Award

Transaction value
Shares
+198,171
Change %
+71%
Price
$3.28*
Shares after
478,671
Date
16 Sep 2026
Ownership
By LLC
Footnotes
F1, F2
CLNN holding

common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,973
Date
16 Sep 2026
Ownership
Direct
CLNN holding

common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
150,333
Date
16 Sep 2026
Ownership
By LP
Footnotes
F3
CLNN holding

common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
72,997
Date
16 Sep 2026
Ownership
By trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.

Footnote F2

The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest.

Footnote F3

The securities are owned by Kensington Investments, L.P. Ms. Mosca is the chief executive officer of Kensington Investments, L.P. The securities owned by Kensington Investments, L.P. may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Investments, L.P., for which she does not have a pecuniary or profits interest.

Footnote F4

The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary interest or profits interest in the securities held by the Robert C. Gay 1998 Family Trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .